ARYx Therapeutics
From Wikipedia, the free encyclopedia
 |
This article does not cite any sources. (May 2010) (Learn how and when to remove this template message) |
 |
The topic of this article may not meet Wikipedia's general notability guideline. (June 2015) (Learn how and when to remove this template message) |
ARYx Therapeutics, Inc. (OTC Pink: ARYX) is an American biopharmaceutical company, headquartered in Fremont, California, focused on molecular design.
The company uses its RetroMetabolic Drug Design technology to design molecules that retain the efficacy of original and well-established drugs but which are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these original compounds.
